Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher I Li

Showing results (81-90 of 276) with videos related to

Pageof 28
Sort By:
Cancer Causes & Control : CCC|November 13, 2024
Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019Leigh Sheridan, Gaia Pocobelli, Melissa Anderson, et al.
Breast Cancer Research and Treatment|December 3, 2005
Antidepressant use and breast cancer riskChloe Chien, Christopher I Li, Susan R Heckbert, et al.
American Journal of Clinical Oncology|November 29, 2016
The Association Between Out-of-Pocket Costs and Adherence to Adjuvant Endocrine Therapy Among Newly Diagnosed Breast Cancer PatientsAlbert J Farias, Ryan N Hansen, Steven B Zeliadt, et al.
Journal of Managed Care & Specialty Pharmacy|July 27, 2016
Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression AnalysisAlbert J Farias, Ryan N Hansen, Steven B Zeliadt, et al.
American Journal of Respiratory and Critical Care Medicine|September 18, 2012
Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic statusBradley S Quon, Kevin Psoter, Nicole Mayer-Hamblett, et al.
International Journal of Cancer|May 1, 2018
Alcohol, smoking, and risk of Her2-overexpressing and triple-negative breast cancer relative to estrogen receptor-positive breast cancerMichelle L Baglia, Linda S Cook, C Mei-Tzu, et al.
American Journal of Epidemiology|February 5, 2005
Re: "studies with low response proportions may be less biased than studies with high response proportions"Lynda F Voigt, Denise M Boudreau, Noel S Weiss, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 2024
Metabolic Syndrome and Risks of Breast Cancer Outcomes for Luminal, Triple-Negative, and HER2-Overexpressing SubtypesNicole C Loroña, Megan Othus, Kathleen E Malone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2023
Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast CancerNicole C Loroña, Megan Othus, Kathleen E Malone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2020
Determinants of Guideline-Discordant Breast Cancer CareJean A McDougall, Linda S Cook, Mei-Tzu C Tang, et al.
Pageof 28

Showing results (81-90 of 276) with videos related to

Sort By:
Pageof 28
Cancer Causes & Control : CCC|November 13, 2024
Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019Leigh Sheridan, Gaia Pocobelli, Melissa Anderson, et al.
Breast Cancer Research and Treatment|December 3, 2005
Antidepressant use and breast cancer riskChloe Chien, Christopher I Li, Susan R Heckbert, et al.
American Journal of Clinical Oncology|November 29, 2016
The Association Between Out-of-Pocket Costs and Adherence to Adjuvant Endocrine Therapy Among Newly Diagnosed Breast Cancer PatientsAlbert J Farias, Ryan N Hansen, Steven B Zeliadt, et al.
Journal of Managed Care & Specialty Pharmacy|July 27, 2016
Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression AnalysisAlbert J Farias, Ryan N Hansen, Steven B Zeliadt, et al.
American Journal of Respiratory and Critical Care Medicine|September 18, 2012
Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic statusBradley S Quon, Kevin Psoter, Nicole Mayer-Hamblett, et al.
International Journal of Cancer|May 1, 2018
Alcohol, smoking, and risk of Her2-overexpressing and triple-negative breast cancer relative to estrogen receptor-positive breast cancerMichelle L Baglia, Linda S Cook, C Mei-Tzu, et al.
American Journal of Epidemiology|February 5, 2005
Re: "studies with low response proportions may be less biased than studies with high response proportions"Lynda F Voigt, Denise M Boudreau, Noel S Weiss, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 2024
Metabolic Syndrome and Risks of Breast Cancer Outcomes for Luminal, Triple-Negative, and HER2-Overexpressing SubtypesNicole C Loroña, Megan Othus, Kathleen E Malone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 29, 2023
Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast CancerNicole C Loroña, Megan Othus, Kathleen E Malone, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2020
Determinants of Guideline-Discordant Breast Cancer CareJean A McDougall, Linda S Cook, Mei-Tzu C Tang, et al.
Pageof 28